Marshall Wace
KANG

Marshall Wace’s iKang Healthcare Group, Inc. KANG Stock Holding History

Marshall Wace’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-23,018
Closed -$416K – 1208
2016
Q3 		$416K Hold
23,018
– – ﹤0.01% 820
2016
Q2 		$422K Buy
+23,018
New +$463K ﹤0.01% 856
2015
Q1 		– Sell
-338,589
Closed -$5.09M – 1001
2014
Q4 		$5.09M Buy
+338,589
New +$6.03M 0.07% 308

Other funds holding KANG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
ASI
All-Stars Investment Hong Kong $206M AUM 31.57% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Marshall Wace's KANG Position: Q4 2016 in Review

Marshall Wace sold out of iKang Healthcare Group, Inc. (KANG) in Q4 2016, closing a stake of 23,018 shares — an estimated $416K sold.

Marshall Wace first reported a position in KANG in Q4 2014 and held it in 3 quarters. The position peaked at $5.09M in Q4 2014. 60 funds tracked by Wall St. Rank hold KANG as of Q4 2016.

  • Marshall Wace reported no remaining iKang Healthcare Group, Inc. position as of Q4 2016 after selling out during the quarter.
  • Marshall Wace sold 23,018 iKang Healthcare Group, Inc. shares in Q4 2016, an estimated $416K.
  • Marshall Wace first reported a position in iKang Healthcare Group, Inc. in Q4 2014 and held it in 3 quarters.
  • Marshall Wace's iKang Healthcare Group, Inc. position peaked at $5.09M in Q4 2014.
  • 60 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q4 2016.

Based on Marshall Wace's 13F filing for Q4 2016, filed 10 Feb 2017.